Cell-type related and spatial variation in the expression of integrins in cutaneous tumors.
Integrins constitute a group of transmembrane proteins which mediate cell-cell and cell-matrix interactions. Previous studies have shown both increased and decreased expression of integrins in relation to malignancy and invasion. In the present study, we investigated integrin distribution in cutaneous tumors by using monoclonal antibodies on frozen tissue sections. Antibodies to integrin subunits alpha v, alpha 3, alpha 4, alpha 5, alpha 6, beta 1 and beta 3 were used. The study was designed to explore (i) the association between integrin expression and the tumor type, and (ii) the effect on the integrin expression of the location of the tumor, i.e. whether it grows intraepidermally or within various compartments of the dermis (papillary or reticular). Beta 1, beta 3 and alpha 3 were strongly or moderately expressed in the epithelial and stromal cells of basal cell carcinomas (BCC), seborrheic keratoses, solar keratoses, dermatofibromas (DF), and showed a variable expression in the nevic cells of benign and dysplastic nevocellular nevi. alpha v and in alpha 5 appeared strongly expressed in the stromal cells of BCC and DF, while only a focal, often weak staining was seen in nevic cells and in the epithelial cells of BCCs. In some nevocellular nevi, they were only expressed, together with alpha 4, in the deep-seated nevic cells in the reticular dermis. alpha 6 was expressed by tumor cells of BCCs and nevocellular nevi only within the dermo-epidermal junction. In seborrheic keratosis and solar keratosis a basement membrane-associated staining pattern for alpha 6 was seen in the basal cell layer, with focal discontinuities in solar keratosis.(ABSTRACT TRUNCATED AT 250 WORDS)
Tuominen
H
H
Department of Pathology, University of Oulu, Finland.
Junttila
T
T
Karvonen
J
J
Kallioinen
M
M
D000911:Antibodies, Monoclonal; D002280:Basal Cell Carcinoma / Q000276:immunology; D018219:Histiocytoma, Benign Fibrous / Q000276:immunology; D006801:Humans; D016023:Integrins / Q000032:analysis*; D007642:Keratosis / Q000209:etiology / Q000276:immunology; D017492:Keratosis, Seborrheic / Q000276:immunology; D012878:Skin Neoplasms / Q000276:immunology* / Q000473:pathology*; D013472:Sunlight / Q000009:adverse effects
D000911:Antibodies, Monoclonal; D016023:Integrins